Trial Outcomes & Findings for OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO (NCT NCT02819011)
NCT ID: NCT02819011
Last Updated: 2020-02-27
Results Overview
Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)
COMPLETED
PHASE2
44 participants
baseline to 6 months
2020-02-27
Participant Flow
Participant milestones
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Overall Study
STARTED
|
22
|
22
|
|
Overall Study
COMPLETED
|
15
|
17
|
|
Overall Study
NOT COMPLETED
|
7
|
5
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO
Baseline characteristics by cohort
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
Total
n=44 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
73.7 years
STANDARD_DEVIATION 6.3 • n=99 Participants
|
75.6 years
STANDARD_DEVIATION 6.5 • n=107 Participants
|
74.7 years
STANDARD_DEVIATION 6.4 • n=206 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=99 Participants
|
14 Participants
n=107 Participants
|
31 Participants
n=206 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=99 Participants
|
8 Participants
n=107 Participants
|
13 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
2 Participants
n=99 Participants
|
2 Participants
n=107 Participants
|
4 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
20 Participants
n=99 Participants
|
20 Participants
n=107 Participants
|
40 Participants
n=206 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
0 Participants
n=107 Participants
|
0 Participants
n=206 Participants
|
|
Region of Enrollment
United States
|
22 participants
n=99 Participants
|
22 participants
n=107 Participants
|
44 participants
n=206 Participants
|
PRIMARY outcome
Timeframe: baseline to 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
Hip sway (motion of hip joints in three dimensions) measured by wearable sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Hip Sway Change From Baseline to 6 Months
Baseline
|
3.65 degree^2
Standard Deviation 3.22
|
3.75 degree^2
Standard Deviation 3.63
|
|
Hip Sway Change From Baseline to 6 Months
@6Month
|
2.15 degree^2
Standard Deviation 1.24
|
3.89 degree^2
Standard Deviation 2.15
|
PRIMARY outcome
Timeframe: baseline to 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
Ankle sway (motion of ankle joint in three dimensions) measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Ankle Sway Change From Baseline to 6 Months
Baseline
|
3.50 degree^2
Standard Deviation 3.74
|
3.21 degree^2
Standard Deviation 2.43
|
|
Ankle Sway Change From Baseline to 6 Months
@6Month
|
1.03 degree^2
Standard Deviation 0.69
|
3.56 degree^2
Standard Deviation 2.54
|
PRIMARY outcome
Timeframe: baseline to 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
Center of Mass (COM) sway measured by wearable inertial sensors while wearing their own shoes compared to the orthopedic shoes and compared to orthopedic shoes plus Ankle-Foot Orthosis (AFO)
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Center of Mass (COM) Sway Change Baseline to 6 Months
Baseline
|
0.71 cm^2
Standard Deviation 0.50
|
0.85 cm^2
Standard Deviation 0.65
|
|
Center of Mass (COM) Sway Change Baseline to 6 Months
@6Month
|
0.32 cm^2
Standard Deviation 0.18
|
0.76 cm^2
Standard Deviation 0.54
|
SECONDARY outcome
Timeframe: 6 monthsThe adherence of participants to the prescribed Ankle-Foot Orthosis (AFO) plus walking shoes was quantified using the response to a self-reported question ("How many hours per day did you wear the prescribed footwear?").
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=14 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=13 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Adherence (Hours Per Day to Wear Ankle-Foot Orthosis (AFO))
|
5.4 hours per day
Standard Deviation 3.3
|
5.6 hours per day
Standard Deviation 3.2
|
SECONDARY outcome
Timeframe: Baseline, 12 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 and 12 months. Generalized Estimating Equation Analysis can handle such missing data
Fall incidents during the study
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Fall Incidents
Baseline
|
2.27 falls per year precedent
Standard Deviation 4.17
|
1.82 falls per year precedent
Standard Deviation 4.19
|
|
Fall Incidents
@12Month
|
0.80 falls per year precedent
Standard Deviation 1.27
|
0.94 falls per year precedent
Standard Deviation 1.25
|
SECONDARY outcome
Timeframe: Baseline, 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
Concern for falling is quantified by Falls Efficacy Scale - International (FES-I) questionnaire. Scores range from minimum 16 (no concern about falling) to maximum 64 (severe concern about falling). Higher score indicate worse performance.
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Concern for Falling Change Form Baseline to 6 Months
Baseline
|
32.8 score on a scale
Standard Deviation 10.7
|
33.3 score on a scale
Standard Deviation 11.5
|
|
Concern for Falling Change Form Baseline to 6 Months
@6Month
|
27.0 score on a scale
Standard Deviation 9.0
|
30.1 score on a scale
Standard Deviation 13.9
|
SECONDARY outcome
Timeframe: baseline to 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
Physical activity level for 24 hours while wearing their own shoes compared to the walking shoes and compared to walking shoes plus Ankle-Foot Orthosis (AFO). To quantify physical activity, number of taken steps per day was monitored using a pendant wearable sensor called, PAMSys (Biosensics, MA, USA).
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Physical Activity Level
Baseline
|
4017 number of steps per day
Standard Deviation 2008
|
3847 number of steps per day
Standard Deviation 3645
|
|
Physical Activity Level
@6Month
|
4872 number of steps per day
Standard Deviation 2657
|
4297 number of steps per day
Standard Deviation 2735
|
SECONDARY outcome
Timeframe: assessed at 1, 3, 6, and 12 months, month 12 reportedNumber of participants with adverse events reported during the study. Adverse events was inquired at 1 months, 3 months, 6 months, 12 months after the baseline, and summed at 12 months. If the participant has at least one adverse event reported in any assessed time frame, the participant will be categorized as the participant with adverse event.
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Number of Participants With Adverse Events
|
0 Participants
|
0 Participants
|
SECONDARY outcome
Timeframe: 6 monthsThe participants perceived usefulness of ease of use of wearing Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) based on questionnaires of A technology acceptance model (TAM). Perceived usefulness was assessed using two questions (i.e., "I feel more stable when standing," and "I feel more stable when walking"). Perceived ease of use was assessed using two questions (i.e., "Was easy to take on and off," and "Was comfortable to wear"). The Likert scale (6-point scale from 0-5) was used to quantify how much they disagreed with each statement, including "strongly disagree," "disagree," "somewhat disagree," "somewhat agree," "agree," and "strongly agree," respectively. In this paper, responses were only categorized as positive (3-5 points) or negative (0-2 points) attitudes towards the use of AFO plus walking shoes.
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=14 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Percentage of Participants Who Found the Device Useful and Easy to Use
perceived usefulness
|
79 percentage of participants
|
—
|
|
Percentage of Participants Who Found the Device Useful and Easy to Use
perceived ease of use
|
93 percentage of participants
|
—
|
SECONDARY outcome
Timeframe: baseline, 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
stride velocity measured in single-task walking with normal speed
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Stride Velocity
Baseline
|
0.80 m/sec
Standard Deviation 0.23
|
0.81 m/sec
Standard Deviation 0.27
|
|
Stride Velocity
6 months
|
0.88 m/sec
Standard Deviation 0.27
|
0.88 m/sec
Standard Deviation 0.30
|
SECONDARY outcome
Timeframe: baseline, 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
stride time measured in single task walking with normal speed
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Stride Time
Baseline
|
1.27 seconds
Standard Deviation 0.18
|
1.24 seconds
Standard Deviation 0.21
|
|
Stride Time
6 months
|
1.25 seconds
Standard Deviation 0.23
|
1.21 seconds
Standard Deviation 0.18
|
SECONDARY outcome
Timeframe: baseline, 6 monthsPopulation: Some participants in AFO and No AFO groups withdrew from study in 6 months. Mixed Model Analysis can handle such missing data
stride length measured in single-task walking with normal speed
Outcome measures
| Measure |
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) for the duration of the study.
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO): Subjects will be provided with a pair of New Balance 813 shoes plus a custom made Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO)
|
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
n=22 Participants
This group will be provided with a pair of New Balance 813 shoes for the duration of the study.
Control: Subjects will be provided with a pair of New Balance 813 shoes
|
|---|---|---|
|
Stride Length
Baseline
|
0.98 meters
Standard Deviation 0.17
|
0.96 meters
Standard Deviation 0.22
|
|
Stride Length
6 months
|
1.05 meters
Standard Deviation 0.22
|
1.01 meters
Standard Deviation 0.27
|
Adverse Events
Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
No Moore Balance Brace (MBB) Ankle-Foot Orthosis (AFO) Group
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: GT60